Mailing aims to reassure psychiatrists
With its best-selling antipsychotic drug the target of thousands of legal claims, Eli Lilly and Co. is trying to reassure psychiatrists they face little malpractice risk for prescribing such drugs.

With its best-selling antipsychotic drug the target of thousands of legal claims, Eli Lilly and Co. is trying to reassure psychiatrists they face little malpractice risk for prescribing such drugs.
Contact:
Copyright © 2005 Malpractice-Central.com All Rights Reserved